Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 736 AL 750

A systematic review of preclinical studies exploring the role of insulin signalling in executive function and memory

Ottomana AM, Presta M, O'Leary A, Sullivan M, Pisa E, Laviola G, Glennon JC, Zoratto F, Slattery DA, Macrì S.

Neurosci Biobehav Rev. 2023 Dec;155:105435. doi: 10.1016/j.neubiorev.2023.105435. Epub 2023 Oct 31.

Recent advancement in therapeutic strategies for Alzheimer's disease: Insights from clinical trials

Khan T, Waseem R, Shahid M, Ansari J, Ahanger IA, Hassan I, Islam A.

Ageing Res Rev. 2023 Dec;92:102113. doi: 10.1016/j.arr.2023.102113. Epub 2023 Oct 31.

Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine

Maisam M, Khan MT, Lodhi MS, Mou K, Liu Z, Wei D.

Front Biosci (Landmark Ed). 2023 Oct 20;28(10):258. doi: 10.31083/j.fbl2810258.

[Efectividad de las terapias no farmacológicas en personas con alzheimer: una revisión sistemática.]

Ruíz-Hernández M, Mur-Gomar R, Montejano-Lozoya R.

Rev Esp Salud Publica. 2023 Oct 18;97:e202310086.

Evaluation of clinical benefits of treatments for Alzheimer's disease

Liu KY, Walsh S, Brayne C, Merrick R, Richard E, Howard R.

Lancet Healthy Longev. 2023 Nov;4(11):e645-e651. doi: 10.1016/S2666-7568(23)00193-9.

Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation-neglected multidimensional regulation of microglia

Zhang X, Chen X, Zhang L, Sun Y, Liang Y, Li H, Zhang Y.

Neurochem Int. 2023 Dec;171:105639. doi: 10.1016/j.neuint.2023.105639. Epub 2023 Nov 3.

Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease

Mani S, Dubey R, Lai IC, Babu MA, Tyagi S, Swargiary G, Mody D, Singh M, Agarwal S, Iqbal D, Kumar S, Hamed M, Sachdeva P, Almutary AG, Albadrani HM, Ojha S, Singh SK, Jha NK.

J Alzheimers Dis. 2023;96(3):877-912. doi: 10.3233/JAD-220700.

Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis

Yang J, Shi X, Wang Y, Ma M, Liu H, Wang J, Xu Z.

J Alzheimers Dis. 2023;96(3):927-945. doi: 10.3233/JAD-230593.

A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial

Banerjee S, Farina N, Henderson C, High J, Stirling S, Shepstone L, Fountain J, Ballard C, Bentham P, Burns A, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Swart AM, Telling T, Tabet N.

Health Technol Assess. 2023 Oct;27(23):1-108. doi: 10.3310/VPDT7105.

[Alzheimer's disease. Current evidence on the preventive role of nutrition]

Lorenzo-Mora AM, Lozano-Estevan MDC, Ghazi Y, González-Rodríguez LG.

Nutr Hosp. 2023 Nov 22;40(Spec No2):41-45. doi: 10.20960/nh.04954.

Neuronal insulin signaling and resistance: a balancing act of kinases and phosphatases

Sharma M, Yadav Y, Dey CS.

J Endocrinol. 2023 Dec 1;260(1):e230151. doi: 10.1530/JOE-23-0151. Print 2024 Jan 1.

Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel

Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Albuhadily AK, Albukhaty S, Sulaiman GM, Batiha GE.

Ageing Res Rev. 2023 Dec;92:102119. doi: 10.1016/j.arr.2023.102119. Epub 2023 Nov 4.

Neuroprotective Mechanisms of Salidroside in Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies

Zhang N, Nao J, Dong X.

J Agric Food Chem. 2023 Nov 22;71(46):17597-17614. doi: 10.1021/acs.jafc.3c06672. Epub 2023 Nov 7.

Gut microbiome-targeted therapies for Alzheimer's disease

Zhang T, Gao G, Kwok LY, Sun Z.

Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.

Current status of amyloid-targeting immunotherapies for Alzheimer's disease

Tabor GT, Holtzman DM.

Sci Transl Med. 2023 Nov 8;15(721):eadk9993. doi: 10.1126/scitranslmed.adk9993. Epub 2023 Nov 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias